LIORESAL Solution for intrathecal injection / infusion Ref.[6373] Active ingredients: Baclofen

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2024  Publisher: Novartis Pharmaceuticals UK Limited, Trading as Ciba Laboratories, 2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ, United Kingdom

Product name and form

Lioresal Intrathecal Injection 50micrograms/1ml.

Lioresal Intrathecal Infusion 10mg/5ml.

Lioresal Intrathecal Infusion 10mg/20ml.

Pharmaceutical Form

Solutions for intrathecal injection and intrathecal infusion.

Qualitative and quantitative composition

Active substance:

b-(Aminomethyl)-p-chlorohydrocinnamic acid (= baclofen), a racemic mixture of the R, (-) and S, (+) isomers

One ampoule of 1 ml contains 50 micrograms baclofen, (50 micrograms/ml).

One ampoule of 5 ml contains 10 mg baclofen, (2000 micrograms/ml).

One ampoule of 20 ml contains 10 mg baclofen, (500 micrograms/ml).

Excipient with known effect:

Each ampoule of Lioresal Intrathecal 10 mg/20 mL contains 70.81 mg sodium.

For excipients see section 6.1 List of excipients.

Active Ingredient Description
Baclofen

Baclofen depresses monosynaptic and polysynaptic reflex transmission, probably by stimulating the GABAB-receptors. This stimulation in turn inhibits the release of the excitatory amino acids glutamate and aspartate. Neuromuscular transmission is unaffected by baclofen. Baclofen also exerts an antinociceptive effect.

List of Excipients

Sodium chloride
Water for injections

Pack sizes and marketing

Colourless glass ampoules, glass type I, according to Ph. Eur.

Marketing authorization holder

Novartis Pharmaceuticals UK Limited, Trading as Ciba Laboratories, 2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ, United Kingdom

Marketing authorization dates and numbers

Lioresal Intrathecal Injection 50micrograms/1ml: PL 00101/0500

Lioresal Intrathecal Infusion 10mg/20ml: PL 00101/0501

Lioresal Intrathecal Infusion 10mg/5ml: PL 00101/0502

Lioresal Intrathecal Injection 50micrograms/1ml: 31 January 2003

Lioresal Intrathecal Infusion 10mg/20ml: 31 January 2003

Lioresal Intrathecal Infusion 10mg/5ml: 3 September 2004

Drugs

Drug Countries
LIORESAL Austria, Australia, Brazil, Canada, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Japan, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.